BAISIOS

baisios-logo

Baisios is a developer of tumor immune cell therapy technology and is dedicated to the growth of the tumor biotherapy industry.

#SimilarOrganizations #Financial #Website #More

BAISIOS

Industry:
Biotechnology Genetics Medical

Founded:
2008-01-01

Address:
Fengtai, Beijing, China

Country:
China

Website Url:
http://www.bioon.com.cn

Total Employee:
51+

Status:
Active

Contact:
010-83682606

Technology used in webpage:
Domain Not Resolving CrUX Top 50m Common Name Invalid PHP Shockwave Flash Embed Chinese Server Location Red Hat Enterprise Linux Baidu Share Alibaba Cloud CDN Apache 2.0


Similar Organizations

base-therapeutics-logo

Base Therapeutics

Best Bio is a developer of cell therapy products and gene therapy products.

bo-shengji-logo

Bo Shengji

Bo Shengji is a biotech company that develops tumor cell immunotherapy technology and products for anti-cancer drugs, kits, etc.

entrada-therapeutics-logo

Entrada Therapeutics

Entrada Therapeutics is a developer of novel therapeutics intended to treat devastating diseases.

eutilex-logo

Eutilex

Eutilex is a develops immunotherapy technology, anti tumor T cell therapy and antibody therapeutics, and other technology products.

ever-supreme-bio-technology-logo

Ever Supreme Bio Technology

Ever Supreme Bio Technology is engaged in the research and development of cell gene therapies

gracell-biotechnologies-logo

Gracell Biotechnologies

Gracell Biotechnologies is a developer of cancer immune therapy designed to treat cancer.

next-generation-gene-therapeutics-logo

Next Generation Gene Therapeutics

Next Generation Gene Therapeutics is a healthcare company that engages in the research and development of gene therapy.

stem-cell-medicine-logo

Stem Cell Medicine

Stem Cell Medicine is a developer of cellular therapies in tissue repair and for the treatment of inflammatory disorders.

Investors List

sirnaomics_image

Sirnaomics

Sirnaomics investment in Series B - Baisios

xiamen-high-tech-innovation-center_image

Xiamen High-Tech Innovation Center

Xiamen High-Tech Innovation Center investment in Series B - Baisios

beijing-science-sun-pharmaceutical_image

Beijing Science Sun Pharmaceutical

Beijing Science Sun Pharmaceutical investment in Series B - Baisios

green-pine-capital-partners_image

Green Pine Capital Partners

Green Pine Capital Partners investment in Series B - Baisios

rongyu-venture-capital_image

Rongyu Venture Capital

Rongyu Venture Capital investment in Series A - Baisios

Official Site Inspections

http://www.bioon.com.cn Semrush global rank: 706.05 K Semrush visits lastest month: 44.18 K

  • Host name: 123.207.218.165
  • IP address: 123.207.218.165
  • Location: Beijing China
  • Latitude: 39.9288
  • Longitude: 116.3889
  • Timezone: Asia/Shanghai

Loading ...

More informations about "Baisios"

生物谷 - 新发现,新技术,新产业 - 生物医药新媒体门户

生物谷,中国专业的生物医药学网站,提供生物医药领域的资讯信息,以及与生物产业,新药开发,生物医药行业报告,生物 ...See details»

BioonGroup(生物谷) - LinkedIn

BioonGroup(生物谷) | 758 followers on LinkedIn. 生物谷|BioonGroup 创始于2001年,目前已发展成为医药生物行业第一的中文媒介平台和专业服务提供商。依托 ...See details»

关于我们 - 生物谷

生物谷一直深耕于生物医药领域,旗下生物谷网站(bioon.com)已成为生物行业用户关注度很高的行业平台, 在生物行业具备较高知名度和影响力。 生物谷依托互联网,面向生物医药行业 …See details»

Bioon.com - The Org

Bioon.com focuses on the bio-industry information platform. Industries. Biotechnology, Health Care +1See details»

公司专区 - 生物谷

AlphaFold 解决了数十年来蛋白质结构预测的难题,并展示了机器学习如何帮助我们理解生物学;而现在,机会在于推进和应用最新的生成式人工智能技术,从头设计蛋白质 ...See details»

Bioon - Overview, News & Similar companies | ZoomInfo.com

Who is Bioon 生物谷|BioonGroup 创始于2001年,目前已发展成为医药生物行业第一的中文媒介平台和专业服务提供商。 依托互联网,面向医药生物行业企业、研发机构、高校、园区以及政 …See details»

生物在线 - 让科研更便捷 :生命科学专业网,试剂,仪器,抗体, …

生物在线,生物谷网站旗下生物科研服务专业平台,生物在线围绕生物医药科研和开发领域,提供从各种仪器,试剂,耗材等产品,到技术服务方案等综合服务体系See details»

Bioon.com.cn - Overview, News & Similar companies - ZoomInfo

Bioon.com.cn is a company that operates in the Biotechnology industry. It employs 21-50 people and has $1M-$5M of revenue. The company is headquart ered in China. Read More. …See details»

BIO ON | Nature always finds the solution

BIO ON offers you the opportunity to discover and use an exceptional natural polymer: PHAs. — The Golden Section is a symbol, but it is also an infinite path that we have undertaken. Nature …See details»

公司介绍-BioonGroup-生物在线 - viewpoint.bioon.com.cn

展位号: BIOON-669b95299a5. 展台参观: 493411. 产品总数: 118. 信用积分: 523See details»

上海比昂生物医药科技有限公司 官方首页 - 生物在线

比昂生物慢病毒载体技术研发中心是专业的慢病毒和rnai技术提供商.2008年7月25日在上海比昂生物慢病毒载体研发中心正式实施上海市科委,浦东新区科委资助慢病毒载体产业化基地项目.为 …See details»

生物谷会议频道

Isfo 2025|国际类器官大会 2025-05-09 2024(第十届)肠道微生态与健康研讨会 2024-12-20 2023(第三届) 3d细胞培养与类器官研讨会 2023-05-19 2023合成生物学与细胞智能制造大 …See details»

Bio-on - Crunchbase Company Profile & Funding

Bio-on operates in the bioplastic sector conducting applied research and development of modern bio-fermentation technologies in the field of eco-sustainable and completely naturally …See details»

BIO ON | Our Innovation

N. WO2020109841A1 — Flexible, biodegradable, and biocompatible supercapacitor Bioon. N. WO2020049337A1 — Medical device for the regeneration of a damaged nerve Bioon. N. …See details»

BIOON - 上海北昂医疗技术有限公司 官方首页 - 生物在线

Mar 28, 2013 上海北昂医疗技术有限公司是一家专注、专业从事检验医学产品生产、推广和销售的医疗技术公司,以生产、推广和销售显微医学图像软件为基础,在服务国内众多医学检验界 …See details»

BioInd 官方首页 - 生物在线

以色列Biological Industries (BioInd) 公司始于1981年,专注于为生物技术和生物医学领域提供安全高品质的细胞培养系列,一贯秉承“用户需求为第一”的宗旨,在研发,生产及供货等各个方面, …See details»

Bio-on 2025 Company Profile: Valuation, Investors, Acquisition

Bio-on General Information Description. Producer of bioplastics created to be used in the cosmetic and pharmaceutical fields. The company's products include a linear polyester …See details»

New survey: U.S. biotechs warn tariffs could impede access to …

4 days ago WASHINGTON (March 26, 2025) -- Today, the Biotechnology Innovation Organization (BIO) released results from a membership survey that underscores the …See details»

Drugmakers sound alarm on possible Trump tariff impacts

3 days ago Trump signed an executive order Feb. 1 to impose 10% tariffs—later doubled to 20%— on imports from China and 25% on those from Canada and Mexico.See details»

生物谷 - 新发现,新技术,新产业 - 生物医药新媒体门户

从干细胞培育出“眼中血管”!Stem Cells:构建血管化视网膜类器官,助力眼科疾病研究新突破. 研究利用人诱导多能干细胞构建出血管化视网膜类器官,其尺寸增大、神经元更成熟,且在模拟 …See details»

linkstock.net © 2022. All rights reserved